Drugs Safety Labeling Updates
Drugs Safety Labeling Updates
| Scientific Name | Trade Name | Updated Section | Safety-Related Labeling Changes | Date |
|---|---|---|---|---|
| Atezolizumab | Tecentriq | 4.8 Undesirable effects | Pericarditis, pericardial effusion, cardiac tamponade | May,2023 |
| Selpercatinib | Retsevmo | 4.4 Special Warnings and Special Precautions for Use, 4.8 Undesirable effects | Interstitial Lung Disease /Pneumonitis | May,2023 |
| Meloxicam | Mobic | 4.4 Special Warnings and Special Precautions for Use | Fixed drug eruption | May,2023 |
| Calcium Chloride | Calcium Chloride 10% In Plastic Container | 4.3 Contraindications | Ceftriaxone use | May,2023 |
| Ketorolac | Ketothrom | 4.4 Special Warnings and Special Precautions for Use | Increased risk of gastro-intestinal anastomotic leak | May,2023 |
| Ropinirole | Requip | 4.8 Undesirable effects | Spontaneous penile erection and Hiccups | Apr,2023 |